KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Other Non-Current Assets (2016 - 2026)

HCA Healthcare (HCA) has disclosed Other Non-Current Assets for 17 consecutive years, with $326.0 million as the latest value for Q1 2026.

  • For Q1 2026, Other Non-Current Assets rose 44.25% year-over-year to $326.0 million; the TTM value through Mar 2026 reached $326.0 million, up 44.25%, while the annual FY2025 figure was $255.0 million, 10.87% up from the prior year.
  • Other Non-Current Assets hit $326.0 million in Q1 2026 for HCA Healthcare, up from $255.0 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $514.0 million in Q2 2022 and bottomed at $184.0 million in Q4 2023.
  • Average Other Non-Current Assets over 5 years is $290.1 million, with a median of $255.0 million recorded in 2025.
  • Year-over-year, Other Non-Current Assets tumbled 61.87% in 2023 and then skyrocketed 54.5% in 2024.
  • HCA Healthcare's Other Non-Current Assets stood at $298.0 million in 2022, then crashed by 38.26% to $184.0 million in 2023, then increased by 25.0% to $230.0 million in 2024, then rose by 10.87% to $255.0 million in 2025, then increased by 27.84% to $326.0 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $326.0 million, $255.0 million, and $277.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.